SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sylvester80 who wrote (1225693)5/1/2020 6:11:12 PM
From: Tenchusatsu1 Recommendation

Recommended By
locogringo

  Read Replies (2) of 1572408
 
Sly,
Leaked Study Data Finds No Benefits Of Remdesivir On Coronavirus Patients, Sending Gilead Stock Tumbling
That was from a week ago, and that leaked study was done in China.

The results of that study were actually inconclusive because China is seeing very few new cases of COVID-19 these days.

Of course, China is also trying to steal Remdesivir from right under our noses, as I mentioned in Tenchu's Thoughts: Message 32635125

Hence I'd bet that Gilead shut down the trial in China because China is not a trustworthy partner in the drug's R&D.

It wouldn't surprise me if you claimed to have made money on BrightGene's stock, the company that is currently manufacturing a copy of that drug ...

Tenchusatsu
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News